Novel biomarkers in heart failure

Several new biomarkers have been recently described in Heart Failure (HF) syndrome either in stable chronic patients as in the settings of acute decompensation. Biomarkers are used to diagnose disease risk, to predict outcome and to tailor treatment to individuals.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news162893169.html">Novel biomarkers in heart failure</a></p> <p>Several new biomarkers have been recently described in Heart Failure (HF) syndrome either in stable chronic patients as in the settings of acute decompensation. Biomarkers are used to diagnose disease risk, to predict outcome and to tailor treatment to individuals.</p>